Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA recruitment status change indicates no longer looking for participants. The record version has been updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a version update of the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history shows a new revision entry (v3.5.4) and removes the previous revision (v3.5.3), updating the version sequence in the history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s platform revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a general software release with no apparent change to the displayed clinical trial record details.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry, v3.5.2, was added to the history and the older v3.5.0 entry was removed.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded version v3.5.0 to the history and removed version v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.